Severe acute respiratory syndrome (SARS) Woodhead M., Ewig S., Torres A. Eur Respir J 2003; 21: 739-740 |   |
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Ewig S., Torres A. Eur Respir J 2003; 21: 741-742 |   |
Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis Koulouris N.G., Retsou S., Kosmas E., Dimakou K., Malagari K., Mantzikopoulos G., Koutsoukou A., Milic-Emili J., Jordanoglou J. Eur Respir J 2003; 21: 743-748 |    |
Rigid bronchoscopy induces bacterial translocation: an experimental study in rats Nayci A., Atis S., Talas D.U., Ersoz G. Eur Respir J 2003; 21: 749-752 |    |
Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53 Mascaux C., Martin B., Verdebout J.M., Meert A.P., Ninane V., Sculier J.P. Eur Respir J 2003; 21: 753-758 |    |
Transcription factor activation and mitogenic synergism in airway smooth muscle cells Ediger T.L., Schulte N.A., Murphy T.J., Toews M.L. Eur Respir J 2003; 21: 759-769 |    |
Increased eNO and pulmonary iNOS expression in eNOS null mice Cook S., Vollenweider P., Menard B., Egli M., Nicod P., Scherrer U. Eur Respir J 2003; 21: 770-773 |    |
Increased vascular endothelial growth factor in acute eosinophilic pneumonia Nishigaki Y., Fujiuchi S., Yamazaki Y., Matsumoto H., Takeda A., Fujita Y., Okamoto K., Fujikane T., Shimizu T., Kikuchi K. Eur Respir J 2003; 21: 774-778 |    |
Chlamydia species as a cause of community-acquired pneumonia in Canada Marrie T.J., Peeling R.W., Reid T., De Carolis E., the Canadian Comm... Eur Respir J 2003; 21: 779-784 |    |
The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Rocha M., Pereira S., Ferreira L., Barros H. Eur Respir J 2003; 21: 785-788 |    |
Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients Rabinovich R.A., Figueras M., Ardite E., Carbo N., Troosters T., Filella X., Barbera J.A., Fernandez-Checa J.C., Argiles J.M., Roca J. Eur Respir J 2003; 21: 789-794 |    |
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Gerrits C.M.J.M., Herings R.M.C., Leufkens H.G.M., Lammers J-W.J. Eur Respir J 2003; 21: 795-798 |    |
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions Buttner C., Lun A., Splettstoesser T., Kunkel G., Renz H. Eur Respir J 2003; 21: 799-803 |    |
Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma Hoshino M., Aoike N., Takahashi M., Nakamura Y., Nakagawa T. Eur Respir J 2003; 21: 804-809 |    |
Bronchodilator tolerance: the impact of increasing bronchoconstriction Wraight J.M., Hancox R.J., Herbison G.P., Cowan J.O., Flannery E.M., Taylor D.R. Eur Respir J 2003; 21: 810-815 |    |
Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler(R) DPI Newhouse M.T., Patel P., Parry-Billings M. Eur Respir J 2003; 21: 816-820 |    |
Social position and mortality from respiratory diseases in males and females Prescott E., Godtfredsen N., Vestbo J., Osler M. Eur Respir J 2003; 21: 821-826 |    |
Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data Arif A.A., Delclos G.L., Lee E.S., Tortolero S.R., Whitehead L.W. Eur Respir J 2003; 21: 827-833 |    |
Transient early wheeze is not associated with impaired lung function in 7-yr-old children Lau S., Illi S., Sommerfeld C., Niggemann B., Volkel K., Madloch C., Gruber C., Nickel R., Forster J., Wahn U., the Multicentre A... Eur Respir J 2003; 21: 834-841 |    |
Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Dik W.A., Versnel M.A., Naber B.A., Janssen D.J., van Kaam A.H., Zimmermann L.J.I. Eur Respir J 2003; 21: 842-847 |    |
Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation? Labiris N.R., Nahmias C., Freitag A.P., Thompson M.L., Dolovich M.B. Eur Respir J 2003; 21: 848-854 |    |
Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO Jones A.T., Hansell D.M., Evans T.W. Eur Respir J 2003; 21: 855-861 |    |
Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats Hampl V., Bibova J., Povysilova V., Herget J. Eur Respir J 2003; 21: 862-865 |    |
Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers Vehmas T., Kivisaari L., Huuskonen M.S., Jaakkola M.S. Eur Respir J 2003; 21: 866-871 |    |
Spirometry in young children: should computer-animation programs be used during testing? Gracchi V., Boel M., van der Laag J., van der Ent C.K. Eur Respir J 2003; 21: 872-875 |    |
To clip or not to clip? Noseclips for spirometry Chavasse R., Johnson P., Francis J., Balfour-Lynn I., Rosenthal M., Bush A. Eur Respir J 2003; 21: 876-878 |    |
Diagnosing occupational asthma: how, how much, how far? Moscato G., Malo J-L., Bernstein D. Eur Respir J 2003; 21: 879-885 |    |
Varicella pneumonia in adults Mohsen A.H., McKendrick M. Eur Respir J 2003; 21: 886-891 |    |
Pulmonary hypertension in chronic obstructive pulmonary disease Barbera J.A., Peinado V.I., Santos S. Eur Respir J 2003; 21: 892-905 |    |
Recurrent tracheal mass Meysman M., Noppen M., De Mey J., Van Herreweghe R., Pipeleers-Maricha... M., Vincken W. Eur Respir J 2003; 21: 906-908 |   |
Efficacy of acupuncture in asthma Hansell A. Eur Respir J 2003; 21: 909 |   |
Asthma variability Stempel D.A. Eur Respir J 2003; 21: 909-910 |   |
From the Authors Zhang J., Yu C., Holgate S.T., Reiss T.F. Eur Respir J 2003; 21: 909-910 |   |
Genomic DNA extraction from small amounts of serum to be used for α1-antitrypsin genotype analysis. S. Andolfatto, F. Namour, A-L. Garnier, F. Chabot, J-L. Gueant, I. Aimone-Gastin. Eur Respir J 2003; 21: 911 |   |
Effect of oxygen on breath markers of oxidative stress. M. Phillips, R.N. Cataneo, J. Greenberg, R. Grodman, R. Gunawardena, A. Naidu. Eur Respir J 2003; 21: 911 |   |
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. W. Szafranski, A. Cukier, A. Ramirez, G. Menga, R. Sansores, S. Nahabedian, S. Peterson, H. Olsson. Eur Respir J 2003; 21: 912 |   |